NCT02366819 2026-03-30
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
University of Chicago
Phase 4 Suspended
Clinical Trials
9 trialsNCT03942328 2026-02-24
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Mayo Clinic
Phase 1/2 Recruiting
NCT04037007 2025-05-01
Efficacy of Fistulotomy for Biliary Cannulation
Coordinación de Investigación en Salud, Mexico
Phase NA Recruiting
NCT06376773 2024-04-19
Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.
Fujian Medical University
Completed
NCT02784353 2022-11-17
PReHeBP
Asan Medical Center
Phase NA Completed
NCT04722120 2022-02-14
Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC
Seoul National University Hospital
Phase NA Completed
NCT02889679 2018-12-20
Underwater Resection of Non-pedunculated Colorectal Lesions
VA Northern California Health Care System
Phase NA Completed
NCT01561014 2018-07-02
Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Wake Forest University Health Sciences
Phase 1 Completed
NCT00482625 2014-10-16
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Terminated